Advertisement

Clinimetric Assessment in Psychosomatic Medicine

  • Fiammetta Cosci
  • Giovanni A. Fava
Chapter
Part of the Integrating Psychiatry and Primary Care book series (IPPC)

Abstract

“Clinimetrics” is the term introduced by Alvan R. Feinstein in the early 1980s to indicate a domain concerned with indexes, rating scales, and other expressions that are used to describe or measure symptoms, physical signs, and other clinical phenomena. Macroanalysis is a helpful clinimetric tool to identify the relationships between biological and psychosocial variables and the individual targets for medical intervention. The present chapter illustrates how clinimetrics may help expanding the narrow range of information that is currently used in psychosomatic medicine. It will focus on the clinimetric approach, on the limitations of the current traditional nosography (i.e., the DSM-5), and on the assessment of psychosocial syndromes via the Diagnostic Criteria for Psychosomatic Research (DCPR)—revised. They have been recently presented in an updated version based on insights derived from studies carried out so far and encompass allostatic overload, type A behavior, alexithymia, the spectrum of maladaptive illness behavior, demoralization, irritable mood, and somatic symptoms secondary to a psychiatric disorder. Clinimetrics represents a perspective of psychosomatic medicine providing an intellectual home for clinical judgment, whose implementation is likely to improve outcomes both in clinical research and practice.

Keywords

Psychosomatic Assessment Clinimetrics Macroanalysis Diagnostic Criteria for Psychosomatic Medicine DCPR DSM-5 Nosography Classification Diagnosis Psychosocial syndromes 

References

  1. 1.
    Feinstein AR. Clinical judgment. Baltimore: Williams & Wilkins; 1967.Google Scholar
  2. 2.
    Feinstein AR. Clinimetrics. New Haven: Yale University Press; 1987.CrossRefGoogle Scholar
  3. 3.
    Feinstein AR. The pre-therapeutic classification of comorbidity in chronic disease. J Chronic Dis. 1970;23:455–68.CrossRefPubMedGoogle Scholar
  4. 4.
    deGroot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56:221–9.CrossRefGoogle Scholar
  5. 5.
    Cloninger CR. Implications of comorbidity for the classification of mental disorders: the need for a psychobiology of coherence. In: Maj M, Gaebel W, Lopez-Ibor JJ, Sartorius N, editors. Psychiatric diagnosis and classification. Chichester: Wiley; 2002. p. 79–105.CrossRefGoogle Scholar
  6. 6.
    Emmelkamp PMG. The additional value of clinimetrics needs to be established rather than assumed. Psychother Psychosom. 2004;73:142–4.  https://doi.org/10.1159/000076450.CrossRefPubMedGoogle Scholar
  7. 7.
    Fava GA, Sonino N. Psychosomatic assessment. Psychother Psychosom. 2009;78:333–41.  https://doi.org/10.1159/000235736.CrossRefGoogle Scholar
  8. 8.
    Emmelkamp PMG, Bouman TK, Scholing A. Anxiety disorders. Chichester: Wiley; 1993.Google Scholar
  9. 9.
    Cosci F, Fava GA. Staging of mental disorders: systematic review. Psychother Psychosom. 2013;82:20–34.  https://doi.org/10.1159/000342243.CrossRefPubMedGoogle Scholar
  10. 10.
    Feinstein AR. An analysis of diagnostic reasoning. I. The domains and disorders of clinical macrobiology. Yale J Biol Med. 1973;46:212–32.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Fava GA, Cosci F, Sonino N. Current psychosomatic practice. Psychother Psychosom. 2017;86:13–30.  https://doi.org/10.1159/000448856.CrossRefPubMedGoogle Scholar
  12. 12.
    Fava GA, Tomba E, Grandi S. The road to recovery from depression. Psychother Psychosom. 2007;76:260–5.  https://doi.org/10.1159/000104701.CrossRefPubMedGoogle Scholar
  13. 13.
    Fava GA. Well-being therapy: current indications and emerging perspectives. Psychother Psychosom. 2016;85:136–45.  https://doi.org/10.1159/000444114.CrossRefPubMedGoogle Scholar
  14. 14.
    Fava GA, Rafanelli C, Tomba E. The clinical process in psychiatry: a clinimetric approach. J Clin Psychiatry. 2012;73:177–84.  https://doi.org/10.4088/JCP.10r06444.CrossRefPubMedGoogle Scholar
  15. 15.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.CrossRefGoogle Scholar
  16. 16.
    Fava GA, Bech P. The concept of euthymia. Psychother Psychosom. 2016;85:1–5.  https://doi.org/10.1159/000441244.CrossRefPubMedGoogle Scholar
  17. 17.
    Hasler G. Well-being: an important concept for psychotherapy and psychiatric neuroscience. Psychother Psychosom. 2016;85:255–61.  https://doi.org/10.1159/000447268.CrossRefPubMedGoogle Scholar
  18. 18.
    Bech P. Clinimetric dilemmas in outcome scales for mental disorders. Psychother Psychosom. 2016;85:323–6.  https://doi.org/10.1159/000448810.CrossRefPubMedGoogle Scholar
  19. 19.
    Basch E. Patient-reported outcomes- harnessing patients’ voices to improve clinical care. N Engl J Med. 2017;376:105–8.  https://doi.org/10.1056/NEJMp1611252.CrossRefPubMedGoogle Scholar
  20. 20.
    Piolanti A, Offidani E, Guidi J, Gostoli S, Fava GA, Sonino N. Use of the psychosocial index: a sensitive tool in research and practice. Psychother Psychosom. 2016;85:337–45.  https://doi.org/10.1159/000447760.CrossRefPubMedGoogle Scholar
  21. 21.
    Cosci F, Svicher A, Bech P. The family assessment device: a clinimetric analysis. Psychother Psychosom. 2016;85:241–3.  https://doi.org/10.1159/000445438.CrossRefPubMedGoogle Scholar
  22. 22.
    Horwitz RI, Hayes-Conroy A, Singer BH. Biology, social environment, and personalized medicine. Psychother Psychosom. 2017;86:5–10.  https://doi.org/10.1159/000452134.CrossRefPubMedGoogle Scholar
  23. 23.
    Sirri L, Fava GA. Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry. 2013;25:19–30.  https://doi.org/10.3109/09540261.2012.726923.CrossRefPubMedGoogle Scholar
  24. 24.
    van den Heuvel OA, Veale D, Stein DJ. Hypochondriasis: considerations for ICD-11. Rev Bras Psiquiatr. 2014;36:21–7.CrossRefPubMedGoogle Scholar
  25. 25.
    Calkins AW, Berman NC, Wilhelm S. Recent advances in research on cognition and emotion in OCD: a review. Curr Psychiatry Rep. 2013;15:357.  https://doi.org/10.1007/s11920-013-0357-4.CrossRefPubMedGoogle Scholar
  26. 26.
    Veale D, Gournay K, Dryden W, Boocock A, Shah F, Willson R, et al. Body dysmorphic disorder: a cognitive behavioural model and a pilot randomised controlled trial. Behav Res Ther. 1996;34:717–29.CrossRefPubMedGoogle Scholar
  27. 27.
    Stone J, Carson A, Duncan R, Coleman R, Roberts R, Warlow C, et al. Symptoms “unexplained by organic disease” in 1144 new neurology out-patients: how often does the diagnosis change at follow-up? Brain. 2009;132:2878–88.  https://doi.org/10.1093/brain/awp220.CrossRefPubMedGoogle Scholar
  28. 28.
    Lipowski ZJ. Somatization: the experience and communication of psychological distress as somatic symptoms. Psychother Psychosom. 1987;47:160–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Härter M, Baumeister H, Reuter K, Jacobi F, Höfler M, Bengel J, et al. Increased 12-month prevalence rates of mental disorders in patients with chronic somatic diseases. Psychother Psychosom. 2007;76:354–60.  https://doi.org/10.1159/000107563.CrossRefPubMedGoogle Scholar
  30. 30.
    Engel GL. Psychological aspects of gastrointestinal disorders. In: Reiser MF, editor. American handbook of psychiatry. New York: Basic Books; 1975. p. 653–92.Google Scholar
  31. 31.
    Pilowsky I. Abnormal illness behaviour. Chichester: Wiley; 1997.Google Scholar
  32. 32.
    Cosci F, Fava GA. The clinical inadequacy of the DSM-5 classification of somatic symptom and related disorders: an alternative trans-diagnostic model. CNS Spectr. 2016;21:310–7.  https://doi.org/10.1017/S1092852915000760.CrossRefPubMedGoogle Scholar
  33. 33.
    Sirri L, Fava GA, Sonino N. The unifying concept of illness behavior. Psychother Psychosom. 2013;82:74–81.  https://doi.org/10.1159/000343508.CrossRefPubMedGoogle Scholar
  34. 34.
    Lilienfeld SO, Smith SF, Watts AL. Issues in diagnosis: conceptual issues and controversies. In: Craighead WE, Miklowitz DJ, Craighead LW, editors. Psychopathology: history, diagnosis, and empirical foundations. 2nd ed. Hoboken: Wiley; 2013. p. 1–35.Google Scholar
  35. 35.
    Widiger TA. Classification and diagnosis: historical development and contemporary issues. In: Maddux JE, Winstead BA, editors. Psychopathology: foundations for contemporary understanding. Mahwah: Lawrence Erbaum Associates; 2005. p. 69–91.Google Scholar
  36. 36.
    Shear MK, Simon N, Wall M, Zisook S, Neimeyer R, Duan N, et al. Complicated grief and related bereavement issues for DSM-5. Depress Anxiety. 2011;28:103–17.  https://doi.org/10.1002/da.20780.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Pies RW. The bereavement exclusion and DSM-5: an update and commentary. Innov Clin Neurosci. 2014;11:19–22.PubMedPubMedCentralGoogle Scholar
  38. 38.
    Fava GA. Rational use of antidepressant drugs. Psychother Psychosom. 2014;83:197–204.  https://doi.org/10.1159/000362803.CrossRefGoogle Scholar
  39. 39.
    Millon T. On the nature of taxonomy in psychopathology. In: Last CG, Hersen M, editors. Issues in diagnostic research. New York: Plenum Press; 1987. p. 3–85.CrossRefGoogle Scholar
  40. 40.
    Tyrer P, Seivewright N, Ferguson B, Tyrer J. The general neurotic syndrome: a coaxial diagnosis of anxiety, depression and personality disorder. Acta Psych Scand. 1992;58:201–6.CrossRefGoogle Scholar
  41. 41.
    Tyrer P, Tyrer H, Guo B. The general neurotic syndrome: a re-evaluation. Psychother Psychosom. 2016;85:193–7.  https://doi.org/10.1159/000444196.CrossRefPubMedGoogle Scholar
  42. 42.
    Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, et al. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom. 1995;63(1):1–8.  https://doi.org/10.1159/000288931.CrossRefPubMedGoogle Scholar
  43. 43.
    Porcelli P, Sonino N. Psychological factors affecting medical conditions. A new classification for DSM-V. Basel: Karger; 2007.CrossRefGoogle Scholar
  44. 44.
    Porcelli P, Bellomo A, Quartesan R, Altamura M, Inso S, Ciannameo I, et al. Psychosocial functioning in consultation-liaison psychiatry patients. Psychother Psychosom. 2009;78:352–8.  https://doi.org/10.1159/000235739.CrossRefPubMedGoogle Scholar
  45. 45.
    Wise TN. Diagnostic criteria for psychosomatic research are necessary for DSM-V. Psychother Psychosom. 2009;78:330–2.  https://doi.org/10.1159/000235735.CrossRefPubMedGoogle Scholar
  46. 46.
    Basińska MA, Woźniewicz A. Occurrence of diagnostic criteria for psychosomatic research syndromes in polish patients with chronic illness. Psychother Psychosom. 2016;8:386–7.  https://doi.org/10.1159/000447243.CrossRefGoogle Scholar
  47. 47.
    De Caro MF, Laera D, De Robertis F, Taurino A. Diagnostic criteria for psychosomatic research and psychosocial functioning in multiple sclerosis. Psychother Psychosom. 2016;85:384–5.  https://doi.org/10.1159/000446706.CrossRefPubMedGoogle Scholar
  48. 48.
    Desai G, Chaturvedi SK. Do diagnostic criteria for psychosomatic research explain diagnosis of medically unexplained somatic symptoms. Psychother Psychosom. 2016;85:121–2.  https://doi.org/10.1159/000441063.CrossRefPubMedGoogle Scholar
  49. 49.
    Huang WL, Liao SC. Psychometric properties of the chinese version of the diagnostic criteria for psychosomatic research. Psychother Psychosom. 2017;86:119–20.  https://doi.org/10.1159/000450714.CrossRefPubMedGoogle Scholar
  50. 50.
    Porcelli P, Guidi J. The clinical utility of the diagnostic criteria for psychosomatic research: a review of studies. Psychother Psychosom. 2015;84:265–72.  https://doi.org/10.1159/000430788.CrossRefPubMedGoogle Scholar
  51. 51.
    McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093–101.CrossRefPubMedGoogle Scholar
  52. 52.
    McEwen BS. Epigenetic interactions and the brain-body communication. Psychother Psychosom. 2017;86:1–4.CrossRefPubMedGoogle Scholar
  53. 53.
    McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev. 2007;87:873–904.  https://doi.org/10.1152/physrev.00041.2006.CrossRefPubMedGoogle Scholar
  54. 54.
    Waeldin S, Vogt D, Linden M, Hellhammer DH. Frequency of perceived poststress symptoms in inpatients, outpatients and healthy controls: the role of perceived exhaustion and stress. Psychother Psychosom. 2016;85:36–44.  https://doi.org/10.1159/000438866.CrossRefPubMedGoogle Scholar
  55. 55.
    Friedman M, Rosenman RH. Type a behavior and your heart. New York: Knopf; 1974.Google Scholar
  56. 56.
    Sirri L, Fava GA, Guidi J, Porcelli P, Rafanelli C, Bellomo A, et al. Type a behavior: a reappraisal of its characteristics in cardiovascular disease. Int J Clin Pract. 2012;66:854–61.  https://doi.org/10.1111/j.1742-1241.2012.02993.x.CrossRefPubMedGoogle Scholar
  57. 57.
    De Vries AM, Forni V, Voellinger R, Stiefel F. Alexithymia in cancer patients: review of the literature. Psychother Psychosom. 2012;81:79–86.  https://doi.org/10.1159/000330888.CrossRefPubMedGoogle Scholar
  58. 58.
    Porcelli P, Bagby RM, Taylor GJ, De Carne M, Leandro G, Todarello O. Alexithymia as predictor of treatment outcome in patients with functional gastrointestinal disorders. Psychosom Med. 2003;65:911–8.CrossRefPubMedGoogle Scholar
  59. 59.
    Fava GA, Grandi S. Differential diagnosis of hypochondriacal fears and beliefs. Psychother Psychosom. 1991;55:114–9.CrossRefPubMedGoogle Scholar
  60. 60.
    Noyes R, Carney CP, Langbehn DR. Specific phobia of illness: search for a new subtype. J Anxiety Disord. 2004;18:531–45.  https://doi.org/10.1016/S0887-6185(03)00041-0.CrossRefPubMedGoogle Scholar
  61. 61.
    Kellner R. Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom. 1994;61:4–24.CrossRefPubMedGoogle Scholar
  62. 62.
    Engel GL. Conversion symptoms. In: Mac Bryde CM, Blacklow RS, editors. Signs and symptoms. Philadelphia: Lippincott; 1970. p. 650–99.Google Scholar
  63. 63.
    Porcelli P, Fava GA, Rafanelli C, Bellomo A, Grandi S, Grassi L, et al. Anniversary reactions in medical patients. J Nerv Ment Dis. 2012;200:603–6.  https://doi.org/10.1097/NMD.0b013e31825bfb2e.CrossRefPubMedGoogle Scholar
  64. 64.
    Goldbeck R. Denial in physical illness. J Psychosom Res. 1997;43:575–93.CrossRefPubMedGoogle Scholar
  65. 65.
    Frank JD. Persuasion and healing. Baltimore: Johns Hopkins University Press; 1961.Google Scholar
  66. 66.
    Schmale AH, Engel GL. The giving up-given up complex illustrated on film. Arch Gen Psychiatry. 1967;17:133–45.CrossRefGoogle Scholar
  67. 67.
    Tecuta L, Tomba E, Grandi S, Fava GA. Demoralization: a systematic review on its clinical characterization. Psychol Med. 2015;45:673–91.  https://doi.org/10.1017/S0033291714001597.CrossRefPubMedGoogle Scholar
  68. 68.
    Sweeney DR, Tinling DC, Schmale AH. Differentiation of the “giving-up” affects- helplessness and hopelessness. Arch Gen Psychiatry. 1970;23:378–82.CrossRefPubMedGoogle Scholar
  69. 69.
    Snaith RP, Taylor CM. Irritability. Br J Psychiatry. 1985;147:127–36.CrossRefPubMedGoogle Scholar
  70. 70.
    Fava GA. Irritable mood and physical illness. Stress Med. 1987;3:293–9.  https://doi.org/10.1080/00223890701629649.CrossRefGoogle Scholar
  71. 71.
    Chida Y, Steptoe A. The association of anger and hostility with future coronary heart disease: a meta-analytic review of prospective evidence. J Am Coll Cardiol. 2009;53:936–46.CrossRefPubMedGoogle Scholar
  72. 72.
    Sartorius N, Holt RIG, Maj M. Comorbidity of mental and physical disorders. Basel: Karger; 2015.Google Scholar
  73. 73.
    Fava GA, Sonino N. Depression associated with medical illness. CNS Drugs. 1996;5:175–89.CrossRefGoogle Scholar
  74. 74.
    Rafanelli C, Sirri L, Grandi S, Fava GA. Is depression the wrong treatment target for improving outcome in coronary artery disease? Psychother Psychosom. 2013;82:285–91.  https://doi.org/10.1159/000351586.CrossRefPubMedGoogle Scholar
  75. 75.
    Katon WJ. Clinical and health services relationships between major depression, depressive symptoms and general medical illness. Biol Psychiatry. 2003;54:216–26.CrossRefPubMedGoogle Scholar
  76. 76.
    Cosci F, Fava GA, Sonino N. Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom. 2015;84:22–9.  https://doi.org/10.1159/000367913.CrossRefPubMedGoogle Scholar
  77. 77.
    Fava GA, Porcelli P, Rafanelli C, Mangelli L, Grandi S. The spectrum of anxiety disorders in the medically ill. J Clin Psychiatry. 2010;71:910–4.  https://doi.org/10.4088/JCP.10m06000blu.CrossRefPubMedGoogle Scholar
  78. 78.
    Niles AN, Dour HJ, Stanton AL, Roy-Byrne PP, Stein MB, Sullivan G, et al. Anxiety and depressive symptoms and medical illness among adults with anxiety disorders. J Psychosom Res. 2015;78:109–15.  https://doi.org/10.1016/j.jpsychores.2014.11.018.CrossRefPubMedGoogle Scholar
  79. 79.
    Tinetti ME, Fried T. The end of the disease era. Am J Med. 2004;116:179–85.CrossRefPubMedGoogle Scholar
  80. 80.
    Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease—specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351:2870–4.  https://doi.org/10.1056/NEJMsb042458.CrossRefPubMedGoogle Scholar
  81. 81.
    Engel GL. The need for a new medical model: a challenge for biomedicine. Science. 1977;196:129–36.CrossRefGoogle Scholar
  82. 82.
    Starcevic V. Cyberchondria: challenges of problematic online searches for health-related information. Psychother Psychosom. 2017;86:129–33.  https://doi.org/10.1159/000465525.CrossRefPubMedGoogle Scholar
  83. 83.
    Rapp MA, Rieckmann N, Lessman DA, Tang CY, Paulino R, Burg MM, et al. Persistent depressive symptoms after acute coronary syndrome are associated with compromised white matter integrity in the anterior cingulate: a pilot study. Psychother Psychosom. 2010;79:149–55.  https://doi.org/10.1159/000286959.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Forman JP, Stampfer MJ, Curhan GC. Diet and lifestyle risk factors associated with incident hypertension in women. JAMA. 2009;302:401–11.  https://doi.org/10.1001/jama.2009.1060.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192–217.CrossRefPubMedGoogle Scholar
  86. 86.
    Narayan KMV, Kanaya AM, Gregg EW. Lifestyle intervention for the prevention of type 2 diabetes mellitus. Treat Endocrinol. 2003;2:315–20.CrossRefPubMedGoogle Scholar
  87. 87.
    Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders. Psychother Psychosom. 2009;78:265–74.  https://doi.org/10.1159/000228247.CrossRefPubMedGoogle Scholar
  88. 88.
    Balon R. Cognitive-behavioral therapy, psychotherapy and psychosocial interventions in the medically ill. Psychother Psychosom. 2009;78:261–4.  https://doi.org/10.1159/000228246.CrossRefPubMedGoogle Scholar
  89. 89.
    Andersen BL, Yang HC, Farrar WB, Golden-Krentz DM, Emery CF, Thornton LM, et al. Psychologic intervention improves survival for breast cancer patients. Cancer. 2008;113:3450–8.  https://doi.org/10.1002/cncr.23969.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Turk DC, Swanson KS, Tunks ER. Psychological approaches in the treatment of chronic pain patients. Can J Psychiatr. 2008;53:213–23.  https://doi.org/10.1177/070674370805300402.CrossRefGoogle Scholar
  91. 91.
    Lahmann C, Nickel M, Schuster T, Sauer N, Ronel J, Noll-Hussong M, et al. Functional relaxation and guided imagery as complementary therapy in asthma: a randomized controlled clinical trial. Psychother Psychosom. 2009;78:233–9.  https://doi.org/10.1159/000214445.CrossRefPubMedGoogle Scholar
  92. 92.
    van Middendorp H, Geenen R, Sorbi MJ, van Doornen LJ, Bijlsma JW. Health and physiological effects of an emotional disclosure intervention adapted for application at home: a randomized clinical trial in rheumatoid arthritis. Psychother Psychosom. 2009;78:145–51.  https://doi.org/10.1159/000206868.CrossRefPubMedGoogle Scholar
  93. 93.
    Fava GA, Grandi S, Rafanelli C, Fabbri S, Cazzaro M. Expanatory therapy of hypochondriasis. J Clin Psychiatry. 2000;61:317–22.CrossRefPubMedGoogle Scholar
  94. 94.
    Feinstein AR. Clinical judgment revisited: the distraction of quantitative models. Ann Intern Med. 1994;120:799–805.CrossRefPubMedGoogle Scholar
  95. 95.
    Fava GA, Tomba E, Sonino N. Clinimetrics: the science of clinical measurements. Int J Clin Pract. 2012;66(1):11–5.  https://doi.org/10.1111/j.1742-1241.2011.02825.x.CrossRefPubMedGoogle Scholar
  96. 96.
    Sonino N, Peruzzi P. A psychoneuroendocrinology service. Psychother Psychosom. 2009;78:346–51.  https://doi.org/10.1159/000235738.CrossRefPubMedGoogle Scholar
  97. 97.
    Wade DT, Smeets RJEM, Werbunt JA. Research in rehabilitation medicine. Methodological challenges. J Clin Epidemiol. 2010;63:69–74.  https://doi.org/10.1016/j.jclinepi.2009.07.010.CrossRefGoogle Scholar
  98. 98.
    Hart JT. Clinical and economic consequences of patients as producers. J Public Health Med. 1995;17:383–6.PubMedGoogle Scholar
  99. 99.
    Kroenke K. Psychological medicine. BMJ. 2002;324:1536–7.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Health SciencesUniversity of FlorenceFlorenceItaly
  2. 2.Department of PsychologyUniversity of BolognaBolognaItaly
  3. 3.Department of PsychiatryState University of New York at BuffaloBuffaloUSA

Personalised recommendations